Office of the Director, National Institutes of Health; Notice of Meeting, 8387 [07-832]
Download as PDF
<![CDATA[
ycherry on PROD1PC64 with NOTICES
Federal Register / Vol. 72, No. 37 / Monday, February 26, 2007 / Notices
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin Ave.,
Bethesda, MD 20814.
Contact Person: Carole H. Latker, PhD,
Scientific Review Administrator, Office of
Scientific Review, National Institute of
General Medical Sciences, National Institutes
of Health, Natcher Building, Room 3AN–18,
Bethesda, MD 20892, (301) 594–2848,
latkerc@nigms.nih.gov.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Minority Biomedical Research
Support.
Date: March 9, 2007.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Brian R. Pike, PhD, Office
of Scientific Review, National Institute of
General Medical Sciences, National Institutes
of Health, 45 Center Drive, Room 3AN18,
Bethesda, MD 20892, 301–594–3907,
pikebr@mail.nih.gov.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Minority Biomedical Research
Support.
Date: March 12, 2007.
Time: 8:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Rebecca H. Johnson, PhD,
Office of Scientific Review, National Institute
of General Medical Sciences, National
Institutes of Health, Natcher Building, Room
3AN18, Bethesda, MD 20892, 301–594–2771,
johnsonrh@nigms.nih.gov.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; NIH Pathway to Independence
Awards.
Date: March 14–15, 2007.
Time: 7 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Garden Inn, 815 14th Street,
NW., Washington, DC 20005.
Contact Person: Meredith D. TempleO’Connor, PhD, Office of Scientific Review,
National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3AN12C, Bethesda, MD
20892, 301–594–2772,
templeocm@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS.)
VerDate Aug<31>2005
16:03 Feb 23, 2007
Jkt 211001
Dated: February 15, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–833 Filed 2–23–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Recombinant DNA Advisory Committee.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Recombinant DNA
Advisory Committee.
Date: March 14, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: The Recombinant DNA Advisory
Committee will review and discuss selected
human gene transfer protocols as well as
related data management activities. There
will be discussion of developments in gene
transfer for inherited immunodeficiency
disorders.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Floor 6C, Room
10, Bethesda, MD 20892.
Contact Person: Laurie Lewallen, Advisory
Committee Coordinator, Office of
Biotechnology Activities, National Institutes
of Health, 6705 Rockledge Drive, Room 750,
Bethesda, MD 20892–7985, 301–496–9838,
lewallla@od.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www4.od.nih.gov/oba/, where an agenda and
any additional information for the meeting
will be posted when available.
OMB’s ‘‘Mandatory Information
Requirements for Federal Assistance Program
Announcements’’ (45 FR 39592, June 11,
1980) requires a statement concerning the
official government programs contained in
the Catalog of Federal Domestic Assistance.
Normally NIH lists in its announcements the
number and title of affected individual
program for the guidance of the public.
Because the guidance in this notice covers
virtually every NIH and Federal research
program in which DNA recombinant
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
8387
molecule techniques could be used, it has
been determined not to be cost effective or
in the public interest to attempt to list these
programs. Such a list would likely require
several additional pages. In addition, NIH
could not be certain that every Federal
program would be included as many Federal
agencies, as well as private organizations,
both national and international, have elected
to follow the NIH Guidelines. In lieu of the
individual program listing, NIH invites
readers to direct questions to the information
address above about whether individual
programs listed in the Catalog of Federal
Domestic Assistance are affected.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: February 15, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–832 Filed 2–23–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Chondroprotection and Chrondrocyte
Biology.
Date: February 26, 2007.
Time: 1 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
E:\FR\FM\26FEN1.SGM
26FEN1
]]>Agencies
[Federal Register Volume 72, Number 37 (Monday, February 26, 2007)]
[Notices]
[Page 8387]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-832]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the Recombinant DNA Advisory Committee.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Recombinant DNA Advisory Committee.
Date: March 14, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: The Recombinant DNA Advisory Committee will review and
discuss selected human gene transfer protocols as well as related
data management activities. There will be discussion of developments
in gene transfer for inherited immunodeficiency disorders.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Floor 6C, Room 10, Bethesda, MD 20892.
Contact Person: Laurie Lewallen, Advisory Committee Coordinator,
Office of Biotechnology Activities, National Institutes of Health,
6705 Rockledge Drive, Room 750, Bethesda, MD 20892-7985, 301-496-
9838, lewallla@od.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: https://www4.od.nih.gov/oba/, where an agenda and any
additional information for the meeting will be posted when
available.
OMB's ``Mandatory Information Requirements for Federal
Assistance Program Announcements'' (45 FR 39592, June 11, 1980)
requires a statement concerning the official government programs
contained in the Catalog of Federal Domestic Assistance. Normally
NIH lists in its announcements the number and title of affected
individual program for the guidance of the public. Because the
guidance in this notice covers virtually every NIH and Federal
research program in which DNA recombinant molecule techniques could
be used, it has been determined not to be cost effective or in the
public interest to attempt to list these programs. Such a list would
likely require several additional pages. In addition, NIH could not
be certain that every Federal program would be included as many
Federal agencies, as well as private organizations, both national
and international, have elected to follow the NIH Guidelines. In
lieu of the individual program listing, NIH invites readers to
direct questions to the information address above about whether
individual programs listed in the Catalog of Federal Domestic
Assistance are affected.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: February 15, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-832 Filed 2-23-07; 8:45 am]
BILLING CODE 4140-01-M
